

The global Liquid Biopsy Services market size was valued at US$ 1587.7 million in 2023. With growing demand in downstream market, the Liquid Biopsy Services is forecast to a readjusted size of US$ 8021.9 million by 2030 with a CAGR of 26.0% during review period.
The research report highlights the growth potential of the global Liquid Biopsy Services market. Liquid Biopsy Services are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Liquid Biopsy Services. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Liquid Biopsy Services market.
Liquid Biopsy Services refer to the specialized diagnostic services provided by medical laboratories or companies that offer testing and analysis of biomarkers in bodily fluids for disease detection and monitoring.
Key Features:
The report on Liquid Biopsy Services market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Liquid Biopsy Services market. It may include historical data, market segmentation by Type (e.g., CTC Detection, ctDNA Detection), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Liquid Biopsy Services market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Liquid Biopsy Services market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Liquid Biopsy Services industry. This include advancements in Liquid Biopsy Services technology, Liquid Biopsy Services new entrants, Liquid Biopsy Services new investment, and other innovations that are shaping the future of Liquid Biopsy Services.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Liquid Biopsy Services market. It includes factors influencing customer ' purchasing decisions, preferences for Liquid Biopsy Services product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Liquid Biopsy Services market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Liquid Biopsy Services market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Liquid Biopsy Services market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Liquid Biopsy Services industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Liquid Biopsy Services market.
Market Segmentation:
Liquid Biopsy Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
CTC Detection
ctDNA Detection
Exosome Detection
Segmentation by application
Hospital
Third-party Testing Agency
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Rad
Roche
Biocartis
Qiagen
Guardant Health
MDxHealth
OME Care
NeoGenomics Laboraories
Sysmex Inostics
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Liquid Biopsy Services Market Size 2019-2030
2.1.2 Liquid Biopsy Services Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Liquid Biopsy Services Segment by Type
2.2.1 CTC Detection
2.2.2 ctDNA Detection
2.2.3 Exosome Detection
2.3 Liquid Biopsy Services Market Size by Type
2.3.1 Liquid Biopsy Services Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Liquid Biopsy Services Market Size Market Share by Type (2019-2024)
2.4 Liquid Biopsy Services Segment by Application
2.4.1 Hospital
2.4.2 Third-party Testing Agency
2.5 Liquid Biopsy Services Market Size by Application
2.5.1 Liquid Biopsy Services Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Liquid Biopsy Services Market Size Market Share by Application (2019-2024)
3 Liquid Biopsy Services Market Size by Player
3.1 Liquid Biopsy Services Market Size Market Share by Players
3.1.1 Global Liquid Biopsy Services Revenue by Players (2019-2024)
3.1.2 Global Liquid Biopsy Services Revenue Market Share by Players (2019-2024)
3.2 Global Liquid Biopsy Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Liquid Biopsy Services by Regions
4.1 Liquid Biopsy Services Market Size by Regions (2019-2024)
4.2 Americas Liquid Biopsy Services Market Size Growth (2019-2024)
4.3 APAC Liquid Biopsy Services Market Size Growth (2019-2024)
4.4 Europe Liquid Biopsy Services Market Size Growth (2019-2024)
4.5 Middle East & Africa Liquid Biopsy Services Market Size Growth (2019-2024)
5 Americas
5.1 Americas Liquid Biopsy Services Market Size by Country (2019-2024)
5.2 Americas Liquid Biopsy Services Market Size by Type (2019-2024)
5.3 Americas Liquid Biopsy Services Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liquid Biopsy Services Market Size by Region (2019-2024)
6.2 APAC Liquid Biopsy Services Market Size by Type (2019-2024)
6.3 APAC Liquid Biopsy Services Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Liquid Biopsy Services by Country (2019-2024)
7.2 Europe Liquid Biopsy Services Market Size by Type (2019-2024)
7.3 Europe Liquid Biopsy Services Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Liquid Biopsy Services by Region (2019-2024)
8.2 Middle East & Africa Liquid Biopsy Services Market Size by Type (2019-2024)
8.3 Middle East & Africa Liquid Biopsy Services Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Liquid Biopsy Services Market Forecast
10.1 Global Liquid Biopsy Services Forecast by Regions (2025-2030)
10.1.1 Global Liquid Biopsy Services Forecast by Regions (2025-2030)
10.1.2 Americas Liquid Biopsy Services Forecast
10.1.3 APAC Liquid Biopsy Services Forecast
10.1.4 Europe Liquid Biopsy Services Forecast
10.1.5 Middle East & Africa Liquid Biopsy Services Forecast
10.2 Americas Liquid Biopsy Services Forecast by Country (2025-2030)
10.2.1 United States Liquid Biopsy Services Market Forecast
10.2.2 Canada Liquid Biopsy Services Market Forecast
10.2.3 Mexico Liquid Biopsy Services Market Forecast
10.2.4 Brazil Liquid Biopsy Services Market Forecast
10.3 APAC Liquid Biopsy Services Forecast by Region (2025-2030)
10.3.1 China Liquid Biopsy Services Market Forecast
10.3.2 Japan Liquid Biopsy Services Market Forecast
10.3.3 Korea Liquid Biopsy Services Market Forecast
10.3.4 Southeast Asia Liquid Biopsy Services Market Forecast
10.3.5 India Liquid Biopsy Services Market Forecast
10.3.6 Australia Liquid Biopsy Services Market Forecast
10.4 Europe Liquid Biopsy Services Forecast by Country (2025-2030)
10.4.1 Germany Liquid Biopsy Services Market Forecast
10.4.2 France Liquid Biopsy Services Market Forecast
10.4.3 UK Liquid Biopsy Services Market Forecast
10.4.4 Italy Liquid Biopsy Services Market Forecast
10.4.5 Russia Liquid Biopsy Services Market Forecast
10.5 Middle East & Africa Liquid Biopsy Services Forecast by Region (2025-2030)
10.5.1 Egypt Liquid Biopsy Services Market Forecast
10.5.2 South Africa Liquid Biopsy Services Market Forecast
10.5.3 Israel Liquid Biopsy Services Market Forecast
10.5.4 Turkey Liquid Biopsy Services Market Forecast
10.5.5 GCC Countries Liquid Biopsy Services Market Forecast
10.6 Global Liquid Biopsy Services Forecast by Type (2025-2030)
10.7 Global Liquid Biopsy Services Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Bio-Rad
11.1.1 Bio-Rad Company Information
11.1.2 Bio-Rad Liquid Biopsy Services Product Offered
11.1.3 Bio-Rad Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bio-Rad Main Business Overview
11.1.5 Bio-Rad Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Liquid Biopsy Services Product Offered
11.2.3 Roche Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Biocartis
11.3.1 Biocartis Company Information
11.3.2 Biocartis Liquid Biopsy Services Product Offered
11.3.3 Biocartis Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Biocartis Main Business Overview
11.3.5 Biocartis Latest Developments
11.4 Qiagen
11.4.1 Qiagen Company Information
11.4.2 Qiagen Liquid Biopsy Services Product Offered
11.4.3 Qiagen Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Qiagen Main Business Overview
11.4.5 Qiagen Latest Developments
11.5 Guardant Health
11.5.1 Guardant Health Company Information
11.5.2 Guardant Health Liquid Biopsy Services Product Offered
11.5.3 Guardant Health Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Guardant Health Main Business Overview
11.5.5 Guardant Health Latest Developments
11.6 MDxHealth
11.6.1 MDxHealth Company Information
11.6.2 MDxHealth Liquid Biopsy Services Product Offered
11.6.3 MDxHealth Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 MDxHealth Main Business Overview
11.6.5 MDxHealth Latest Developments
11.7 OME Care
11.7.1 OME Care Company Information
11.7.2 OME Care Liquid Biopsy Services Product Offered
11.7.3 OME Care Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 OME Care Main Business Overview
11.7.5 OME Care Latest Developments
11.8 NeoGenomics Laboraories
11.8.1 NeoGenomics Laboraories Company Information
11.8.2 NeoGenomics Laboraories Liquid Biopsy Services Product Offered
11.8.3 NeoGenomics Laboraories Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 NeoGenomics Laboraories Main Business Overview
11.8.5 NeoGenomics Laboraories Latest Developments
11.9 Sysmex Inostics
11.9.1 Sysmex Inostics Company Information
11.9.2 Sysmex Inostics Liquid Biopsy Services Product Offered
11.9.3 Sysmex Inostics Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sysmex Inostics Main Business Overview
11.9.5 Sysmex Inostics Latest Developments
11.10 Menarini Silicon Biosystems
11.10.1 Menarini Silicon Biosystems Company Information
11.10.2 Menarini Silicon Biosystems Liquid Biopsy Services Product Offered
11.10.3 Menarini Silicon Biosystems Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Menarini Silicon Biosystems Main Business Overview
11.10.5 Menarini Silicon Biosystems Latest Developments
11.11 Adaptive Biotechnologies
11.11.1 Adaptive Biotechnologies Company Information
11.11.2 Adaptive Biotechnologies Liquid Biopsy Services Product Offered
11.11.3 Adaptive Biotechnologies Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Adaptive Biotechnologies Main Business Overview
11.11.5 Adaptive Biotechnologies Latest Developments
11.12 Biocept
11.12.1 Biocept Company Information
11.12.2 Biocept Liquid Biopsy Services Product Offered
11.12.3 Biocept Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Biocept Main Business Overview
11.12.5 Biocept Latest Developments
11.13 Angle plc
11.13.1 Angle plc Company Information
11.13.2 Angle plc Liquid Biopsy Services Product Offered
11.13.3 Angle plc Liquid Biopsy Services Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Angle plc Main Business Overview
11.13.5 Angle plc Latest Developments
12 Research Findings and Conclusion
Ìý
Ìý
*If Applicable.